Orexo AB

As of June 30, 2026, Orexo AB carries a market capitalization of 833.39M, placing it among publicly traded companies globally. Its enterprise value stands at 566.39M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Orexo AB's next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Orexo AB has 35.13M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Orexo AB maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Orexo AB recorded 1.30M in income tax expense.

As of the close on October 22, 2026, Orexo AB's stock has declined approximately 86.54% over the past 52 weeks. The 50-day moving average sits at 11.84, while the 200-day moving average is 19.89.

As of June 30, 2026, Orexo AB holds 276.90M in cash and equivalents against 9.90M in total debt, resulting in a net debt position of -276.90M. Total book value stands at 271.30M, with working capital of 149.90M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.